Edwards Lifesciences Corporation (EW) — Financial statements
Income statement, balance sheet, and cash flow for Edwards Lifesciences Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 6,068↑11.5% | 5,440↑8.6% | 5,010↓6.9% | 5,382↑2.9% | 5,233 | |
| Cost of Revenue | 1,327↑18.7% | 1,118↑7.7% | 1,037↓11.1% | 1,167↓4.8% | 1,226 | |
| Gross Profit | 4,741↑9.7% | 4,322↑8.8% | 3,973↓5.8% | 4,215↑5.2% | 4,007 | |
| Operating Expenses | ||||||
| R&D Expenses | 1,079↑2.5% | 1,053↑9.4% | 963↑1.9% | 945↑4.7% | 903 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 2,085↑16.5% | 1,789↑13.1% | 1,583↑1.0% | 1,568↑5.0% | 1,493 | |
| Other Expenses | -60↓159.2% | 101 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 3,105↑5.5% | 2,943↑15.6% | 2,545↑1.3% | 2,513↑4.9% | 2,396 | |
| Total Costs & Expenses | 4,431↑9.1% | 4,061↑13.3% | 3,583↓2.6% | 3,680↑1.6% | 3,622 | |
| Operating Results | ||||||
| Operating Income | 1,636↑18.7% | 1,379↓3.4% | 1,427↓16.2% | 1,702↑5.7% | 1,610 | |
| Depreciation & Amortization | 157↑0.9% | 155↑7.1% | 145↓13.1% | 167↑2.1% | 163 | |
| EBITDA | 1,430↓17.0% | 1,723↑12.3% | 1,535↓21.7% | 1,960↑3.7% | 1,890 | |
| EBIT | 1,273↓18.8% | 1,568↑12.8% | 1,390↓22.5% | 1,794↑3.9% | 1,727 | |
| Interest & Other Income | ||||||
| Net Interest Income | 148↑47.7% | 101↑102.6% | 50↑433.3% | 9↑225.7% | -7 | |
| Interest Income | 148↑23.4% | 120↑79.0% | 67↑89.3% | 36↑104.0% | 17 | |
| Interest Expense | 0.00↓100.0% | 20↑12.5% | 18↓32.8% | 26↑5.6% | 25 | |
| Non-Operating Income | 363↑292.0% | -189↓607.2% | 37↑140.9% | -91↑21.6% | -116 | |
| Other Income / Expenses | -363↓314.5% | 169↑408.6% | -55↓184.5% | 65↓29.0% | 92 | |
| Income Before Tax | 1,273↓17.8% | 1,548↑12.8% | 1,372↓22.3% | 1,767↑3.8% | 1,702 | |
| Income Tax Expense | 217↑42.6% | 152↓0.2% | 152↓37.9% | 246↑23.4% | 199 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 1,056↓24.4% | 1,396↑14.4% | 1,220↓19.8% | 1,522↑1.3% | 1,503 | |
| Net Income from Discontinued Operations | 13↓99.5% | 2,774↑1446.1% | 179 | 0.00 | 0.00 | |
| Net Income | 1,074↓74.3% | 4,175↑197.7% | 1,402↓7.9% | 1,522↑1.3% | 1,503 | |
| Bottom-Line Net Income | 1,074↓74.3% | 4,175↑197.7% | 1,402↓7.9% | 1,522↑1.3% | 1,503 | |
| EPS (Basic) | 1.84↓73.6% | 6.98↑202.2% | 2.31↓6.1% | 2.46↑2.1% | 2.41 | |
| EPS (Diluted) | 1.83↓73.7% | 6.97↑203.0% | 2.30↓5.7% | 2.44↑2.5% | 2.38 | |
| Weighted Average Shares | 585↓2.2% | 598↓1.5% | 607↓2.0% | 619↓0.7% | 623 | |
| Weighted Average Diluted Shares | 586↓2.3% | 599↓1.7% | 609↓2.4% | 624↓1.1% | 631 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.